A voluntary recall has been issued by Sanofi US for it’s Auvi-Q epinephrine auto-injectors. The Auvi-Q recall includes ALL injectors in both the .15mg and .3mg strengths which was dispensed to hospitals, retailers and consumers. The issue around the Auvi-Q recall involves the potentially inaccurate dosage delivery which can be fatal in a case of anaphylaxis.
AUVI-Q RECALL ALERT
If you are using an Auvi-Q device, please visit www.Auvi-Q.